🟢 Icecure Medical is trading 7.64% up in pre-market today amid broad risk-on sentiment

Icecure Medical is trading at $2.11, up +7.64%, most likely amid broad risk-on sentiment as major U.S. indices rise more than 0.5%.

• No new company-specific announcement or overnight filing was identified for September 21, 2026.
• The latest major catalyst was September 10 China NMPA approval for ProSense, now stale relative to this move.
• Firmer futures and overnight U.S.-China optimism support a global move; confidence is medium without a confirmed direct catalyst.